Stock Pulse
Henry Schein (HSIC) will release Q1 2025 earnings on May 5th [2]. Despite a recent 5.5% stock price increase attributed to a broader market rally [1], the company faces a declining consensus EPS estimate and a Zacks Rank of #4 (Sell) [1], [8], with concerns over declining organic revenue, slim projected revenue growth, and declining return on invested capital [5]. While the company received validation for its net-zero emissions targets by 2050 [3] and will showcase its products at the 2025 International Dental Show [6], its stock has declined since its last earnings report [8] and underperformed the S&P 500, with analysts revising estimates downwards [8]. Long-term opportunities exist with potential increased demand for dental consumables due to Utah's water fluoridation ban [4] and a focus on sustainability [3], but negative recent financial performance [7] presents challenges.